BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37599457)

  • 1. Structural and functional characterization of 6-phosphogluconate dehydrogenase in
    Karthika A; Hemavathy N; Amala M; Rajamanikandan S; Veerapandian M; Prabhu D; Vetrivel U; Jung Chen C; Jeyaraj Pandian C; Jeyakanthan J
    J Biomol Struct Dyn; 2024; 42(4):2058-2074. PubMed ID: 37599457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target.
    Haeussler K; Fritz-Wolf K; Reichmann M; Rahlfs S; Becker K
    J Mol Biol; 2018 Oct; 430(21):4049-4067. PubMed ID: 30098336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
    Wadood A; Ulhaq ZU
    J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of in vitro and in silico effect of Fluorophenylthiourea compounds on glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase enzymes.
    Yıldız ML; Demir Y; Küfrevioğlu ÖI
    J Mol Recognit; 2022 Dec; 35(12):e2987. PubMed ID: 36326002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance.
    Sarfraz I; Rasul A; Hussain G; Shah MA; Zahoor AF; Asrar M; Selamoglu Z; Ji XY; Adem Ş; Sarker SD
    Biofactors; 2020 Jul; 46(4):550-562. PubMed ID: 32039535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
    Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
    Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal Structures of 6-Phosphogluconate Dehydrogenase from
    Yu H; Hong J; Seok J; Seu YB; Kim IK; Kim KJ
    J Microbiol Biotechnol; 2023 Oct; 33(10):1361-1369. PubMed ID: 37417004
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure of
    Berneburg I; Stumpf M; Velten AS; Rahlfs S; Przyborski J; Becker K; Fritz-Wolf K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Lin R; Elf S; Shan C; Kang HB; Ji Q; Zhou L; Hitosugi T; Zhang L; Zhang S; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; Mitsche M; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Hurwitz SJ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Lei Q; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
    Nat Cell Biol; 2015 Nov; 17(11):1484-96. PubMed ID: 26479318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions.
    Yao P; Sun H; Xu C; Chen T; Zou B; Jiang P; Du W
    J Biol Chem; 2017 Oct; 292(41):17113-17120. PubMed ID: 28848047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of natural products against enoyl-acyl-carrier-protein reductase in malaria via combined pharmacophore modeling, molecular docking and simulations studies.
    Manhas A; Ghosh A; Verma Y; Das T; Jha PC
    J Biomol Struct Dyn; 2023 Mar; 41(5):2002-2015. PubMed ID: 35043754
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery of dual-target natural antimalarial agents against DHODH and PMT of
    Elamin EM; Eshage SE; Mohmmode SM; Mukhtar RM; Mahjoub M; Sadelin E; Shoaib TH; Edris A; Elshamly EM; Makki AA; Ashour A; Sherif AE; Osman W; Ibrahim SRM; Mohamed GA; Alzain AA
    SAR QSAR Environ Res; 2023; 34(9):709-728. PubMed ID: 37665563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model.
    Zhang Q; Zhang Y; Wang C; Tang H; Ma A; Gao P; Shi Q; Wang G; Shen S; Zhang J; Xia F; Zhu Y; Wang J
    Phytomedicine; 2024 Jul; 129():155657. PubMed ID: 38692076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.
    Chan B; VanderLaan PA; Sukhatme VP
    Biochem Biophys Res Commun; 2013 Sep; 439(2):247-51. PubMed ID: 23973484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
    Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
    Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phthalide derivatives as dihydrofolate reductase inhibitors for malaria: molecular docking and molecular dynamics studies.
    Ibraheem W; Makki AA; Alzain AA
    J Biomol Struct Dyn; 2023 Jul; 41(11):5127-5137. PubMed ID: 35635144
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of
    Rawat R; Verma SM
    J Biomol Struct Dyn; 2021 Sep; 39(14):5148-5159. PubMed ID: 32579074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.